This webinar will discuss the use of antibody-drug conjugates (ADCs) and associated proactive toxicity management to assist patients to adhere to their treatment protocols therefore improving patient outcomes.
ABOUT THE WEBINAR:
This webinar will discuss the use of antibody-drug conjugates (ADCs) and associated proactive toxicity management to assist patients to adhere to their treatment protocols therefore improving patient outcomes.
MEET THE SPEAKERS:

Medical Oncology Nurse Practitioner, CNSA Director, Bendigo Health Cancer Centre
IN COLLABORATION WITH:

Medical Oncology Nurse Practitioner, CNSA Director, Bendigo Health Cancer Centre
Justin Hargreaves (BN, PGDipN(Can&Pall), MAdvNursPrac(NPRAC) is a Nurse Practitioner at Bendigo Cancer Centre, Bendigo Health, Victoria, and previous Chair of the Cancer Nurses Society of Australia (CNSA) Cancer Nurse Practitioner Specialist Practice Network.
He completed his Master of Advanced Nursing Practice at the University of Melbourne in 2010 and was endorsed as a Nurse Practitioner in 2011. He works full-time at Bendigo Health Cancer Centre, where his clinical focus includes patient assessment, management of chemotherapy and immunotherapy-related toxicities, breast cancer survivorship, oral anticancer therapies, and supportive care.
In June 2025, Justin joined the CNSA Board as a Director and looks forward to contributing at a broader strategic level to support professional leadership, influence the future of cancer nursing, and advance innovation in cancer care across Australia.
Please accept {{cookieConsents}} cookies to view this content